{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T08:21:45Z","timestamp":1775118105798,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["americanjournalofsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Surgery"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.amjsurg.2023.03.004","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T16:22:43Z","timestamp":1678206163000},"page":"871-877","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["DCIS: When is accelerated partial breast irradiation an option? A meta-analysis on outcomes and eligibility"],"prefix":"10.1016","volume":"225","author":[{"given":"Vannesza Hendricke","family":"Chua","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce Hazel","family":"Chua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celina Joyce","family":"Aniceto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane April","family":"Antonio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma. Dara Hannah","family":"Harina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen Claire","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.amjsurg.2023.03.004_bib1","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/jnci\/djy220","article-title":"Cancer outcomes in DCIS patients without locoregional treatment","volume":"111","author":"Ryser","year":"2019","journal-title":"JNCI: J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.amjsurg.2023.03.004_bib2","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41588-022-01082-3","article-title":"Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer","volume":"54","author":"Lips","year":"2022","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.amjsurg.2023.03.004_bib3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10911-022-09517-7","article-title":"Ductal carcinoma in situ: molecular changes accompanying disease progression","volume":"27","author":"Wilson","year":"2022","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"2","key":"10.1016\/j.amjsurg.2023.03.004_bib4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10549-005-9101-z","article-title":"The natural history of ductal carcinoma in situ of the breast: a Review","volume":"97","author":"Erbas","year":"2005","journal-title":"Breast Cancer Res Treat"},{"issue":"10215","key":"10.1016\/j.amjsurg.2023.03.004_bib5","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/S0140-6736(19)32514-0","article-title":"Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial","volume":"394","author":"Vicini","year":"2019","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.amjsurg.2023.03.004_bib6","doi-asserted-by":"crossref","DOI":"10.1007\/s11912-015-0473-x","article-title":"Ductal carcinoma in situ: treatment update and current trends","volume":"17","author":"Mitchell","year":"2015","journal-title":"Curr Oncol Rep"},{"issue":"1","key":"10.1016\/j.amjsurg.2023.03.004_bib7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.brachy.2017.09.004","article-title":"The American brachytherapy society consensus statement for Accelerated Partial-breast irradiation","volume":"17","author":"Shah","year":"2018","journal-title":"Brachytherapy"},{"issue":"2","key":"10.1016\/j.amjsurg.2023.03.004_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.prro.2016.09.007","article-title":"Accelerated partial breast irradiation: executive summary for the update of an ASTRO evidence-based consensus statement","volume":"7","author":"Correa","year":"2017","journal-title":"Pract Radiat Oncol"},{"issue":"1","key":"10.1016\/j.amjsurg.2023.03.004_bib9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.radonc.2016.06.019","article-title":"GEC-ESTRO Multicenter Phase 3-trial: accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: early toxicity and patient compliance","volume":"120","author":"Ott","year":"2016","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.amjsurg.2023.03.004_bib10","doi-asserted-by":"crossref","first-page":"691","DOI":"10.6004\/jnccn.2022.0030","article-title":"Breast cancer, version 3.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Gradishar","year":"2022","journal-title":"J Natl Compr Cancer Netw"},{"issue":"5","key":"10.1016\/j.amjsurg.2023.03.004_bib11","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/COC.0000000000000190","article-title":"Seven-year outcomes following accelerated partial breast irradiation stratified by Astro Consensus Groupings","volume":"40","author":"Jawad","year":"2017","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"10.1016\/j.amjsurg.2023.03.004_bib12","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ejca.2014.12.013","article-title":"Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial","volume":"51","author":"Livi","year":"2015","journal-title":"Eur J Cancer"},{"issue":"10","key":"10.1016\/j.amjsurg.2023.03.004_bib13","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1245\/s10434-017-5953-9","article-title":"A single institution retrospective comparison study of Locoregional recurrence after accelerated partial breast irradiation using external beam fractionation compared with whole breast irradiation with 8 years of follow-up","volume":"24","author":"Shah","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.amjsurg.2023.03.004_bib14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.adro.2018.11.004","article-title":"A single-institution experience in the preoperative selection of DCIS patients for IORT USING THE ASTRO consensus guidelines","volume":"4","author":"Chin","year":"2019","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.amjsurg.2023.03.004_bib15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.radonc.2018.12.030","article-title":"Ductal carcinoma in situ and intraoperative partial breast irradiation: who are the best candidates? long-term outcome of a single institution series","volume":"133","author":"Leonardi","year":"2019","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.amjsurg.2023.03.004_bib16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.brachy.2020.11.002","article-title":"Management of ductal carcinoma in situ with accelerated partial breast irradiation brachytherapy: implications for guideline expansion","volume":"20","author":"Mills","year":"2021","journal-title":"Brachytherapy"},{"issue":"4","key":"10.1016\/j.amjsurg.2023.03.004_bib17","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.amjsurg.2009.06.013","article-title":"American Society of Breast Surgeons mammosite radiation therapy system registry trial: ductal carcinoma-in-situ subset analysis\u20144-year data in 194 treated lesions","volume":"198","author":"Keisch","year":"2009","journal-title":"Am J Surg"},{"issue":"3","key":"10.1016\/j.amjsurg.2023.03.004_bib18","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ijrobp.2013.06.2056","article-title":"Prospective multicenter trial evaluating balloon-catheter partial-breast irradiation for ductal carcinoma in situ","volume":"87","author":"Abbott","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.amjsurg.2023.03.004_bib19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijrobp.2010.05.011","article-title":"Outcomes after accelerated partial breast irradiation in patients with Astro consensus statement cautionary features","volume":"81","author":"McHaffie","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.amjsurg.2023.03.004_bib20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/tbj.12516","article-title":"Targeted intraoperative radiotherapy for the management of ductal carcinoma in situ of the breast","volume":"22","author":"Rivera","year":"2015","journal-title":"Breast J"},{"issue":"3","key":"10.1016\/j.amjsurg.2023.03.004_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/0300891618811278","article-title":"External accelerated partial breast irradiation for ductal carcinoma in situ: long-term follow-up from a phase 3 randomized trial","volume":"105","author":"Becherini","year":"2018","journal-title":"Tumori"},{"issue":"2","key":"10.1016\/j.amjsurg.2023.03.004_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2013.06.506","article-title":"Disease control efficacy of ductal carcinoma in situ (DCIS) treated with accelerated partial breast irradiation (APBI)","volume":"87","author":"Lei","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"10.1016\/j.amjsurg.2023.03.004_bib23","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.ejca.2015.05.008","article-title":"Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ \u2013 the LORD study","volume":"51","author":"Elshof","year":"2015","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.amjsurg.2023.03.004_bib24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2559.2010.03568.x","article-title":"Breast cancer precursors revisited: molecular features and progression pathways","volume":"57","author":"Lopez-Garcia","year":"2010","journal-title":"Histopathology"},{"issue":"14","key":"10.1016\/j.amjsurg.2023.03.004_bib25","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1016\/j.ejca.2006.03.019","article-title":"The management of lobular carcinoma in situ (LCIS). is LCIS the same as ductal carcinoma in situ (DCIS)?","volume":"42","author":"Lakhani","year":"2006","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.amjsurg.2023.03.004_bib26","doi-asserted-by":"crossref","DOI":"10.1186\/bcr629","article-title":"The diagnosis and management of pre-invasive breast disease: pathological diagnosis \u2013 problems with existing classifications","volume":"5","author":"Van de Vijver","year":"2003","journal-title":"Breast Cancer Res"},{"issue":"1","key":"10.1016\/j.amjsurg.2023.03.004_bib27","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/path.3990","article-title":"Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and Clonal Selection","volume":"227","author":"Hernandez","year":"2012","journal-title":"J Pathol"},{"issue":"4","key":"10.1016\/j.amjsurg.2023.03.004_bib28","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1054\/bjoc.2000.1618","article-title":"Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ","volume":"84","author":"Bijker","year":"2001","journal-title":"Br J Cancer"},{"issue":"33","key":"10.1016\/j.amjsurg.2023.03.004_bib29","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1200\/JCO.2015.60.8588","article-title":"Surgical excision without radiation for ductal carcinoma in situ of the breast: 12-year results from the ECOG-ACRIN E5194 study","volume":"33","author":"Solin","year":"2015","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.amjsurg.2023.03.004_bib30","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1200\/JCO.2014.57.9029","article-title":"RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation","volume":"33","author":"McCormick","year":"2015","journal-title":"J Clin Oncol"}],"container-title":["The American Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961023001009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961023001009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:27:15Z","timestamp":1757701635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002961023001009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0002961023001009"],"URL":"https:\/\/doi.org\/10.1016\/j.amjsurg.2023.03.004","relation":{},"ISSN":["0002-9610"],"issn-type":[{"value":"0002-9610","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DCIS: When is accelerated partial breast irradiation an option? A meta-analysis on outcomes and eligibility","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjsurg.2023.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}